Fentanyl Cit 600mcg Oraltransmcsl

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Fentanyl Lozenge(FEN ta nil) Pronunciation FEN-ta-nil SIT-rate
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain.This drug is not for mild pain or pain that only lasts a short time (like headaches, toothaches, or pain after surgery).This drug is only for use by people who have been taking pain drugs (opioids) and are used to their effects. Talk with the doctor.
🏷️
Drug Class
Opioid analgesic
🧬
Pharmacologic Class
Opioid agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1998
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

Fentanyl lozenge is a strong opioid pain medicine used only for sudden, severe 'breakthrough' pain in cancer patients who are already taking other opioid pain medicines around-the-clock. It works by changing how your brain and nervous system respond to pain. It is designed to be absorbed through the lining of your mouth, not swallowed whole.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To use this medication properly, follow your doctor's instructions and read all the information provided. Place the lozenge in your mouth between your cheek and lower gum, and gently move it from side to side using the handle. Suck on the oral lozenge without chewing, breaking, or crushing it, and do not swallow it whole. After taking a dose, dispose of the handle in the trash, out of reach of children and pets. If any medication remains on the handle, rinse it with hot water before discarding to ensure the drug is fully dissolved.

Storing and Disposing of Your Medication

Store this medication at room temperature in a dry place, avoiding bathrooms. Keep it in a secure location where children cannot see or access it, and where others cannot reach it. Consider using a locked box or area to safeguard the medication. Keep all medications away from pets. Dispose of unused or expired medications by throwing them away. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of medications, consult your pharmacist, who may be aware of drug take-back programs in your area.

Missing a Dose

If you take this medication regularly and miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, do not take it more frequently than directed by your doctor.
πŸ’‘

Lifestyle & Tips

  • Do not drive or operate heavy machinery until you know how this medicine affects you, as it can cause drowsiness and dizziness.
  • Avoid alcohol and other CNS depressants (e.g., benzodiazepines, sleeping pills) as they can increase the risk of serious side effects like severe drowsiness and breathing problems.
  • Store this medicine securely out of reach of children and pets, preferably in a locked cabinet, due to the high risk of accidental overdose.
  • Properly dispose of any unused or expired lozenges immediately by flushing them down the toilet or using a drug take-back program, as directed by your pharmacist or the medication guide.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Initial dose is typically 200 mcg. Dose is titrated upwards in increments (e.g., 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg) until adequate analgesia is achieved with tolerable side effects for breakthrough cancer pain. Only one lozenge should be used per breakthrough pain episode. A minimum of 4 hours should elapse between doses.
Dose Range: 200 - 1600 mg

Condition-Specific Dosing:

breakthrough_cancer_pain: For management of breakthrough pain in opioid-tolerant adult cancer patients. Opioid tolerance is defined as patients taking at least 60 mg of oral morphine/day, 25 mcg of transdermal fentanyl/hour, 30 mg of oral oxycodone/day, 8 mg of oral hydromorphone/day, or an equianalgesic dose of another opioid for a week or longer.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established in pediatric patients under 16 years of age for breakthrough cancer pain. Use in opioid-tolerant adolescents 16 years and older should follow adult titration guidelines with extreme caution.)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but monitor closely for increased effects.
Moderate: Monitor closely for increased effects and consider lower initial doses or slower titration.
Severe: Monitor closely for increased effects and consider lower initial doses or slower titration due to potential for prolonged half-life and accumulation of fentanyl and its metabolites.
Dialysis: Fentanyl is not significantly dialyzable. Monitor closely for prolonged effects.

Hepatic Impairment:

Mild: No specific dose adjustment recommended, but monitor closely for increased effects.
Moderate: Monitor closely for increased effects and consider lower initial doses or slower titration due to potential for reduced clearance.
Severe: Monitor closely for increased effects and consider lower initial doses or slower titration due to potential for reduced clearance.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Fentanyl is a potent, synthetic opioid analgesic that acts primarily as an agonist at the mu-opioid receptors in the central nervous system (CNS). Its primary therapeutic actions are analgesia and sedation. Other effects include respiratory depression, miosis, euphoria, and physical dependence.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 25-50% (oral transmucosal absorption is variable, with a significant portion swallowed and absorbed via the GI tract)
Tmax: 20-40 minutes (for transmucosal absorption)
FoodEffect: Not applicable for transmucosal administration, but absorption from the GI tract may be affected by gastric motility.

Distribution:

Vd: Approximately 4 L/kg
ProteinBinding: Approximately 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (rapid and extensive)

Elimination:

HalfLife: 3-12 hours (terminal elimination half-life, highly variable)
Clearance: Approximately 0.5 L/hr/kg
ExcretionRoute: Primarily urine (75% as metabolites, <10% as unchanged drug), feces (9% as metabolites)
Unchanged: <10%
⏱️

Pharmacodynamics

OnsetOfAction: 5-15 minutes (for analgesia)
PeakEffect: 20-40 minutes (for analgesia)
DurationOfAction: 1-2 hours (for analgesia, but respiratory depressant effects may last longer)
Confidence: Medium

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF MEDICATION ERRORS, ADDICTION, ABUSE, AND MISUSE, RESPIRATORY DEPRESSION, ACCIDENTAL INGESTION, CYTOCHROME P450 3A4 INTERACTION, AND RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS. Fentanyl oral transmucosal lozenge is indicated only for the management of breakthrough pain in cancer patients 16 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. Patients considered opioid tolerant are those who are taking at least 60 mg of oral morphine/day, 25 mcg of transdermal fentanyl/hour, 30 mg of oral oxycodone/day, 8 mg of oral hydromorphone/day, or an equianalgesic dose of another opioid for a week or longer. Because of the risk of respiratory depression, fentanyl oral transmucosal lozenge is contraindicated in opioid non-tolerant patients. Life-threatening respiratory depression could occur at any dose in opioid non-tolerant patients. Fentanyl oral transmucosal lozenge is subject to the Opioid Analgesic REMS program.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a severe bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk for serotonin syndrome, a severe and potentially deadly condition. Seek medical help right away if you experience:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache

Adrenal Gland Problems: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor immediately if you experience:

Extreme fatigue or weakness
Fainting
Severe dizziness
Upset stomach
Vomiting
Decreased appetite

Other Possible Side Effects

While many people may not experience side effects or may only have mild ones, it's essential to be aware of the following possible side effects:

Dizziness
Drowsiness
Fatigue
Weakness
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Headache
Feeling cold
Sleep disturbances
Excessive sweating
Irritation at the site of administration

If you're concerned about any side effects or have questions, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Extreme drowsiness or difficulty waking up
  • Slow, shallow, or difficult breathing
  • Blue lips or fingernails
  • Pinpoint pupils
  • Feeling dizzy or lightheaded when standing up
  • Confusion or disorientation
  • Unresponsiveness (cannot be awakened)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of certain medications, including buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Presence of mouth sores, which should be discussed with your doctor

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have. This will help ensure your safety while taking this medication. Never start, stop, or change the dose of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and exercise caution when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.

Additionally, regular use of opioid medications like this one can cause dependence. If you need to reduce the dose or stop taking this medication, consult your doctor first, as sudden changes may increase the risk of withdrawal or other severe problems. Follow your doctor's instructions carefully, and report any increased pain, mood changes, suicidal thoughts, or other adverse effects.

Safe Use Guidelines
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.

If your pain worsens, you become more sensitive to pain, or you experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Interactions and Precautions
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this may lead to unsafe and potentially fatal effects.

This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at higher risk.

Long-term Use Considerations
Prolonged use of opioid medications like this one may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation difficulties, contact your doctor.

Maintain good oral hygiene and schedule regular dental check-ups. If you have diabetes, inform your doctor, as some products may contain sugar.

Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek medical attention immediately if your baby appears excessively sleepy, limp, or has breathing difficulties.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe respiratory depression (slowed or stopped breathing)
  • Extreme somnolence progressing to stupor or coma
  • Skeletal muscle flaccidity
  • Cold and clammy skin
  • Pinpoint pupils
  • Bradycardia
  • Hypotension
  • Circulatory collapse
  • Cardiac arrest
  • Death

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Continue to monitor breathing and administer repeated doses of naloxone as needed. Provide supportive care (e.g., oxygen, ventilatory support). Call 1-800-222-1222 (Poison Control) for additional guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI therapy (risk of serotonin syndrome or severe respiratory depression)
  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nelfinavir, saquinavir, troleandomycin, nefazodone) in patients not already receiving fentanyl (risk of increased fentanyl plasma concentrations and potentially fatal respiratory depression)
πŸ”΄

Major Interactions

  • Other CNS depressants (e.g., benzodiazepines, other opioids, sedatives/hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants, alcohol): Increased risk of respiratory depression, profound sedation, coma, and death.
  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nelfinavir, saquinavir, troleandomycin, nefazodone): Increased fentanyl exposure, leading to potentially fatal respiratory depression. If co-administration is necessary, reduce fentanyl dose and monitor closely.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, linezolid): Risk of serotonin syndrome.
  • Mixed agonist/antagonist opioids (e.g., pentazocine, nalbuphine, butorphanol, buprenorphine): May reduce the analgesic effect of fentanyl or precipitate withdrawal symptoms.
🟑

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, fluconazole, grapefruit juice): Increased fentanyl exposure, monitor for respiratory depression.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl exposure, potentially leading to reduced efficacy or withdrawal symptoms.
  • Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
🟒

Minor Interactions

  • Not available (most interactions are significant due to fentanyl's potency)

Monitoring

πŸ”¬

Baseline Monitoring

Pain assessment (intensity, quality, location)

Rationale: To establish baseline pain level and characterize breakthrough pain episodes.

Timing: Prior to initiation of therapy and at each follow-up visit.

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk factors for respiratory depression.

Timing: Prior to initiation of therapy.

Level of consciousness/sedation

Rationale: To assess baseline neurological status and identify risk factors for excessive sedation.

Timing: Prior to initiation of therapy.

Concomitant medications review (especially CNS depressants, CYP3A4 inhibitors/inducers)

Rationale: To identify potential drug interactions that could increase risk of adverse effects.

Timing: Prior to initiation of therapy.

Opioid tolerance status

Rationale: Fentanyl lozenge is only for opioid-tolerant patients; confirm eligibility.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Effectiveness of pain control for breakthrough pain

Frequency: Regularly during titration and ongoing therapy (e.g., daily during titration, weekly/monthly once stable)

Target: Acceptable pain relief with tolerable side effects.

Action Threshold: Inadequate pain relief or excessive side effects warrant dose adjustment or re-evaluation.

Signs of respiratory depression (slow, shallow breathing, cyanosis)

Frequency: During titration, and regularly during stable therapy (e.g., at each visit, patient/caregiver education for home monitoring)

Target: Normal respiratory rate and effort for the patient.

Action Threshold: Respiratory rate <10 breaths/min, shallow breathing, excessive sedation, or unresponsiveness requires immediate medical intervention (e.g., naloxone, emergency services).

Level of sedation/alertness

Frequency: During titration and ongoing therapy

Target: Alert and able to communicate, or easily aroused.

Action Threshold: Excessive drowsiness, difficulty arousing, or unresponsiveness requires intervention.

Signs of opioid-induced constipation

Frequency: Regularly (e.g., at each visit)

Target: Regular bowel movements.

Action Threshold: Constipation requires prophylactic or therapeutic management.

Signs of opioid use disorder (OUD), abuse, or diversion

Frequency: Regularly (e.g., at each visit, through urine drug screens if indicated)

Target: Adherence to prescribed regimen, no signs of misuse.

Action Threshold: Suspicion of OUD or diversion requires intervention and referral.

πŸ‘οΈ

Symptom Monitoring

  • Severe drowsiness
  • Dizziness
  • Confusion
  • Slow or shallow breathing
  • Difficulty breathing
  • Pinpoint pupils
  • Extreme fatigue
  • Unresponsiveness
  • Nausea
  • Vomiting
  • Constipation
  • Itching

Special Patient Groups

🀰

Pregnancy

Use during pregnancy is generally not recommended due to potential for fetal harm, including neonatal opioid withdrawal syndrome (NOWS). Benefits must clearly outweigh risks.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of major congenital malformations (e.g., cardiac defects, neural tube defects) with first-trimester opioid exposure, though data for fentanyl specifically is limited and inconsistent.
Second Trimester: Risk of fetal growth restriction and potential for NOWS if exposure continues.
Third Trimester: High risk of neonatal opioid withdrawal syndrome (NOWS) if used chronically. NOWS can be life-threatening and requires prolonged hospitalization and treatment. Risk of respiratory depression in the neonate if used near delivery.
🀱

Lactation

Fentanyl is excreted into breast milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., sedation, respiratory depression, poor feeding), breastfeeding is not recommended during treatment with fentanyl lozenge. If breastfeeding cannot be avoided, monitor the infant closely for signs of sedation and respiratory depression.

Infant Risk: High (L4 - Possible hazard)
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients under 16 years of age. Use in opioid-tolerant adolescents 16 years and older should follow adult titration guidelines with extreme caution and close monitoring due to potential for increased sensitivity to respiratory depression.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression. Start with lower doses and titrate slowly. Monitor closely for adverse effects, especially respiratory depression and sedation. Consider age-related decreases in renal and hepatic function.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fentanyl lozenge is for opioid-tolerant cancer patients only. Use in opioid-naΓ―ve patients can be fatal due to severe respiratory depression.
  • Strict adherence to the REMS (Risk Evaluation and Mitigation Strategy) program is mandatory for prescribing, dispensing, and patient counseling.
  • Patients and caregivers must be educated on the signs of respiratory depression and the availability and use of naloxone.
  • Accidental ingestion by children or pets is a significant risk and can be fatal. Emphasize secure storage and proper disposal.
  • Dose titration is crucial; start low and go slow, assessing efficacy and tolerability for each breakthrough pain episode.
  • Only one lozenge should be used per breakthrough pain episode. Do not use more than 4 doses per day.
  • Patients should not chew, suck, or swallow the lozenge whole, as this will reduce the transmucosal absorption and may lead to lower efficacy or delayed onset.
πŸ”„

Alternative Therapies

  • Other short-acting opioids for breakthrough pain (e.g., immediate-release oxycodone, hydromorphone, morphine)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild-moderate pain or as adjuncts
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, tricyclic antidepressants) for neuropathic pain
  • Regional nerve blocks or other interventional pain procedures
  • Radiation therapy for localized cancer pain
πŸ’°

Cost & Coverage

Average Cost: Highly variable, typically several hundred to over a thousand USD per 30 lozenges
Generic Available: Yes
Insurance Coverage: Tier 3 or 4 (Specialty/Non-Preferred Brand/Generic), often requires prior authorization and step therapy.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be administered to help counteract the effects. Discuss obtaining and using naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care immediately. When seeking help, be prepared to provide information about the substance involved, the quantity taken, and the time of the incident.